Vitamin C pp 87-106 | Cite as

Vitamin C in Respiratory Diseases

  • P. C. Braga
Conference paper


Free radicals (such as RS, RSO2 , SO3 -•, NO, NO2 , LO, LOO, CCl3 ) and other reactive oxygen species (ROS) (O2 -• , H2O2, HO, HOCl) along with singlet oxygen (1O2) and ozone (O3) are highly reactive chemical agents which may oxidize several biological molecules such as proteins, lipids, and nucleic acids, thereby inducing cellular damage [1].


Cystic Fibrosis Alveolar Macrophage Idiopathic Pulmonary Fibrosis Adult Respiratory Distress Syndrome Epithelial Line Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sies H (1991) Oxidative stress: from basic research to clinical application. In: Crystal RG, Bast A, Roshan-Ali Y (eds) Oxidants and antioxidants: pathophysiological determinants and therapeutic agents. Am J Med 91[Suppl 3C]:31S–38SGoogle Scholar
  2. 2.
    Acworth IN, Bailey B (1995) The handbook of oxidative metabolism. ESA Inc, Chelmsford, MA, USAGoogle Scholar
  3. 3.
    Fehér J, Csomós G, Vereckei A (1985) Free radical reactions in medicine. Springer, Berlin Heidelberg New York, p 39Google Scholar
  4. 4.
    Chaudiere J (1994) Some chemical and biochemical constraints of oxidative stress in living cells. In: Rice-Evans CA, Brandon RH (eds) Free radical damage and its control. Elsevier, Amsterdam, pp 25–66CrossRefGoogle Scholar
  5. 5.
    Sies H (1986) Biochemistry of oxidative stress. Angew Chem Int Ed Engl 25:1058–1071CrossRefGoogle Scholar
  6. 6.
    Weibel ER (1991) Design and morphometry of the pulmonary gas exchanger. In: Crystal RG, West JB (eds) The lung. Scientific Foundation. Raven, New York, pp 711–720Google Scholar
  7. 7.
    Murderly JL, Samet JM (1990) General environment. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 86:962–971CrossRefGoogle Scholar
  8. 8.
    Braga PC (1997) I radicali ossidanti, le patologie polmonari: l’acido ascorbico. Springer, Berlin Heidelberg New York, p 24Google Scholar
  9. 9.
    Freeman B (1994) Free radical chemistry of nitric oxide. Looking at the dark side. Chest 105:795–845Google Scholar
  10. 10.
    Maritz GS (1996) Ascorbic acid protection of lung tissue against damage. In: Harris RJ (ed) Ascorbic acid: biochemistry and biochemical cell biology. Plenum, New York, pp 272–274Google Scholar
  11. 11.
    Doelman CJA, Bast A (1990) Oxygen radicals in lung pathology. Free Radic Biol Med 9:381–400PubMedCrossRefGoogle Scholar
  12. 12.
    Kyrfeldt A, Barnnenberg G, Moldéus P (1993) Free radicals and lung disease. Br Med Bull 49:588–603Google Scholar
  13. 13.
    Tonnel AB, Wallaert B (1990) Oxidants and bronchial inflammatory diseases. Eur Respir J 3:987–988PubMedGoogle Scholar
  14. 14.
    Denholm E, Phan SH (1990) Bleomycin binding sites on alveolar macrophages. J Leukoc Biol 48:519–523PubMedGoogle Scholar
  15. 15.
    Oberley LW, Buethier GR (1979) The production of hydroxyl radical by bleomycin and iron (II). FEBS Lett 97:47–49CrossRefGoogle Scholar
  16. 16.
    Caspary WJ, Lanzo DA, Niziak C (1981) Intermediates in the ferrous oxidase cycle of bleomycin. Biochemistry 20:3868–3875PubMedCrossRefGoogle Scholar
  17. 17.
    Hay J, Schalizeidi S, Laurent G (1991) Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65:81–89PubMedCrossRefGoogle Scholar
  18. 18.
    Nakamura H, Sato S, Takahoghi E (1988) Effects of vitamin E deficiency on bleomycin-induced pulmonary fibrosis in the hamster. Lung 166:161–167PubMedCrossRefGoogle Scholar
  19. 19.
    Weiss RB, Muggia FM (1980) Cytotoxic drug-induced pulmonary disease: update 1980. Am J Med 63:259–266CrossRefGoogle Scholar
  20. 20.
    Bhat M, Royanasakul Y, Weber SL, Mca YCV, Castranova V, Banks DE, Ma JKH (1994) Fluoromicroscopic studies of bleomycin-induced intracellular oxidation in alveolar macrophages and its inhibition by tamine. Environ Health Perspect 102 [Suppl 10]:91–96PubMedGoogle Scholar
  21. 21.
    Holtzman JL, Crankshaw DL, Peterson FG, Polnaszek CF (1981) The kinetics of the aerobic reduction of nitrofurantoin by NADPH-cytochrome P-450 reductase. Mol Pharmacol 20:669–673PubMedGoogle Scholar
  22. 22.
    Martin WJ (1983) Nitrofurantoin: evidence for the oxidant injury of lung parenchyma cells. Am Res Respir Dis 12:482–486Google Scholar
  23. 23.
    Trush MA, Mirunaugh EG, Ginsberg E, Gram TE (1981) In vitro stimulation by paraquat of reactive oxygen-mediated lipid peroxidation in rat lung microsomes. Toxicol Appl Pharmacol 60:279–286PubMedCrossRefGoogle Scholar
  24. 24.
    Vijeyaratnam GS, Corrin B (1971) Experimental paraquat poisoning: a histological and electron-optical study of the changes in the lung. J Pathol 103:123–129PubMedCrossRefGoogle Scholar
  25. 25.
    Smith P, Health D (1976) Paraquat. CRC Crit Rev Toxicol 4:411–445Google Scholar
  26. 26.
    Becklake M (1982) Exposure to asbestos and human disease. N Engl J Med 306:1481–1482CrossRefGoogle Scholar
  27. 27.
    Ziskind M, Jones RN, Weil H (1978) Silicosis: state of the art. Am Rev Respir Dis 113:643–645Google Scholar
  28. 28.
    Dubois CM, Bissonnette E, Rola-Pleszczynski M (1989) Asbestos fibres and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene release tumor necrosis factor. Autoregulatory role of leukotriene B4. Am Rev Respir Dis 139:1257–1264PubMedGoogle Scholar
  29. 29.
    Vallyathan V, Shi X, Dalai NS, Irr W, Castronova V (1988) Generation of free radicals from freshly fractured silica dust. Am Rev Respir Dis 138:1213–1219PubMedGoogle Scholar
  30. 30.
    Gulumian M, Kilroe-Smith TA (1987) Crocidolite-induced lipid peroxidation. Environ Respir 44:254–259CrossRefGoogle Scholar
  31. 31.
    Lovie S, Halliwell B, Cross CE (1997) Adult respiratory distress syndrome: a radicale perspective. In: Sies H (ed) Antioxidants in disease mechanisms and therapy. Academic, San Diego, pp 457–490Google Scholar
  32. 32.
    Henson PM, Johnson RB (1987) Tissue injury in inflammation. Oxidants proteinases and cationic proteins. J Clin Invest 79:669–674PubMedCrossRefGoogle Scholar
  33. 33.
    Baldwin SR, Grum CM, Boxer LA, Simon RH, Ketoi LH, Devall LJ (1986) Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1:11–13PubMedCrossRefGoogle Scholar
  34. 34.
    Bellavite P, Barisoni D, Sorio A, Governa M, Bezoni F, Cassatella MA (1990) The neutrophil: structure and defence function. In: Baggiolini M, Pozzi E, Semenzato G (eds) Neutrophils, lymphocytes and lung. Masson, Paris, pp 2–17Google Scholar
  35. 35.
    Dreisin RB, Schwarz MI, Theofilopoulos AN, Stanford RE (1978) Circulating immune complex in the idiopathic interstitial pneumonias. N Engl J Med 298:353–357PubMedCrossRefGoogle Scholar
  36. 36.
    Borok Z, Trapnell BC, Crystal G (1990) Neutrophils and the pathogenesis of idiopathic pulmonary fibrosis. In: Baggiolini M, Pozzi E, Semenzato G (eds) Neutrophils, lymphocytes and lung. Masson, Paris, pp 111–122Google Scholar
  37. 37.
    Crystal RG (1991) Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. In: Crystal RG, Bast A, Roshan-Ali Y (eds) Oxidants and antioxidants: pathophysiological determinants and therapeutic agents. Am J Med 91 [Suppl 3C]:39S–44SGoogle Scholar
  38. 38.
    Travis J (1990) Neutrophil enzymes and emphysema. In: Baggiolini M, Pozzi E, Semenzato G (eds) Neutrophils, lymphocytes and lung. Masson, Paris, pp 65–74Google Scholar
  39. 39.
    Van der Wliet A, Eiserich JP, Marelich GP, Halliwell B, Cross CE (1997) Oxidative stress in cystic fibrosis: does it occur and does it matter? In: Sies H (ed) Antioxidants in disease mechanisms and therapy. Academic, San Diego, pp 491–513Google Scholar
  40. 40.
    Boat TF, Welsh MJ, Braudet AI (1989) Cystic fibrosis. In: Scriver CR, Beaudet AJ, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 2649–2680Google Scholar
  41. 41.
    Roum JH, Buhl R, McElvaney N (1990) In vitro evaluation of the ability of glutathione to suppress the inflammatory cell derived oxidant burden in respiratory epithelial lining fluid of individuals with cystic fibrosis. Clin Res 38: 440AGoogle Scholar
  42. 42.
    Kennedy TP, Rao NV, Hopkins C, Pennington L, Tolley E, Hoidal JR (1989) Role of reactive oxygen-species in reperfusion injury of the rabbit lung. J Clin Invest 83:1326–1335PubMedCrossRefGoogle Scholar
  43. 43.
    Mc Cord JM (1985) Oxygen-derived free radicals in post-ischaemic tissue injury. N En J Med 312:159–163CrossRefGoogle Scholar
  44. 44.
    Goldhaber JI, Weiss JN (1992) Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 20:118–127PubMedGoogle Scholar
  45. 45.
    Tsao CS (1997) An overview of ascorbic acid chemistry and biochemistry. In: Packer L, Fuchs J (eds) Vitamin C in health and disease. Dekker, New York, pp 25–58Google Scholar
  46. 46.
    Halliwell B, Whiteman M (1997) Antioxidant and prooxidant properties of vitamin C. In: Packer L, Fuchs J (eds) Vitamin C in health and disease. Dekker, New York, pp 59–73Google Scholar
  47. 47.
    Braga PC (1997) I radicali ossidanti, le patologie polmonari: l’acido ascorbico. Springer, Berlin Heidelberg New York, pp 110–115Google Scholar
  48. 48.
    Washko P, Rotrosen D, Levine M (1989) Ascorbic acid transport and accumulation in human neutrophils. J Biol Chem 264:18996–19002PubMedGoogle Scholar
  49. 49.
    Meister A (1992) On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44:1905–1915PubMedCrossRefGoogle Scholar
  50. 50.
    Washko P, Wang Y, Levine M (1993) Ascorbic acid recycling in human neutrophils. J Biol Chem 268:15531–15535PubMedGoogle Scholar
  51. 51.
    Matkovics B, Barabs K, Verga SI, Szabo L, Berencsi G (1982) Some new data to the toxicological effects of paraquat and the therapy. Gen Pharmacol 44:768–773Google Scholar
  52. 52.
    Kau JL, Zaidi SH (1969) Effects of ascorbic acid on pulmonarv silicosis of guinea pigs. Arch Environ Health 19:74–82Google Scholar
  53. 53.
    Khan SG, Ali S, Rahman Q (1990) Protective role of ascorbic acid against asbestos induced toxicity in rat lung: in vitro study. Drug Chem Toxicol 13:249–256PubMedCrossRefGoogle Scholar
  54. 54.
    Cross CE, Forte T, Stocker R Louie S, Yamamoto Y, Ames BN, Frei B (1990) Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome. J Lab Clin Med 115:396–404PubMedGoogle Scholar
  55. 55.
    Schectman G, Byrd JC, Gruchrown HW (1989) The influence of smoking on vitamin C status in adults. Am J Public Health 79:158–162PubMedCrossRefGoogle Scholar
  56. 56.
    Bielory L, Gandhi R (1994) Asthma and vitamin C. Ann Allergy 38:89–96Google Scholar
  57. 57.
    Anah CO, Jarike LN, Baig HA (1980) High dose ascorbic acid in Nigerian asthmatics. Trop Geogr Med 32:132–137PubMedGoogle Scholar
  58. 58.
    Schwartz J, Weiss ST (1990) Dietaly factors and their relationship to respiratory symptoms. Am J Epidemiol 132:67–76PubMedGoogle Scholar
  59. 59.
    Ogilvy CS, Dubois AB, Douglas JS (1981) Effects of ascorbic acid and indomethacin on the airways of healthy male subjects with and without induced bronchoconstric-tion. J Allergy Clin Immunol 67:363–369PubMedCrossRefGoogle Scholar
  60. 60.
    Schwarts J, Weiss ST (1994) Relationship between dietary vitamin C intake and pulmonary function in the First National Health and Nutrition Examination Survey. Am J Clin Nutr 59:110–114Google Scholar
  61. 61.
    Hatch GE (1995) Asthma, inhaled oxidants, and dietary antioxidants. Am J Clin Nutr 61 [Suppl]:625S–630SPubMedGoogle Scholar
  62. 62.
    Olusi SO, Ojutiku 00, Jessop WJE, Iboki MI (1979) Plasma and white blood cell ascorbic acid concentrations in patients with bronchial asthma. Clin Chem Acta 92:161–166CrossRefGoogle Scholar
  63. 63.
    Dawson W, West GB (1965) The nature of the antagonism of bronchospasm in the guinea-pig by ascorbic acid. Br J Pharmacol 17:595–596Google Scholar
  64. 64.
    Pocwiardowska E, Puglisi L (1980) The effects of L-ascorbic acid and prostaglandins on isolated tracheal smooth muscle. Acta Physiol Pol 31:187–194PubMedGoogle Scholar
  65. 65.
    Moshenin V (1987) Effect of vitamin C on N02-induced airway hyperresponsive-ness in normal subjects. Ann Rev Respir Dis 136:1408–1411CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1998

Authors and Affiliations

  • P. C. Braga
    • 1
  1. 1.Centre of Respiratory Pharmacology, Department of Pharmacology, School of MedicineUniversity of MilanItaly

Personalised recommendations